Camlin Fine Sciences Limited (NSE:CAMLINFINE)
271.20
+3.75 (1.40%)
Aug 1, 2025, 3:30 PM IST
Revance Therapeutics Market Cap
Camlin Fine Sciences has a market cap or net worth of 51.02 billion as of August 1, 2025. Its market cap has increased by 147.95% in one year.
Market Cap
51.02B
Enterprise Value
56.14B
Revenue
16.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
$271.20
Market Cap Chart
Since March 30, 2007, Camlin Fine Sciences's market cap has increased from 412.25M to 51.02B, an increase of 12,276.16%. That is a compound annual growth rate of 30.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 51.02B | 132.17% |
Dec 31, 2024 | 21.98B | -3.40% |
Dec 29, 2023 | 22.75B | -9.51% |
Dec 30, 2022 | 25.14B | 51.29% |
Dec 31, 2021 | 16.62B | 6.55% |
Dec 31, 2020 | 15.60B | 52.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UltraTech Cement | 3,608.92B |
Asian Paints | 2,317.23B |
Grasim Industries | 1,871.75B |
Vedanta | 1,697.38B |
Pidilite Industries | 1,461.97B |
Solar Industries India | 1,309.30B |
Shree Cement | 1,103.71B |
Jindal Steel | 1,002.59B |